Measuring the rate of progression in Friedreich ataxia: Implications for clinical trial design

Friedreich ataxia is an autosomal recessive neurodegenerative disorder characterized by ataxia of all four limbs, dysarthria and arreflexia. A variety of measures are currently used to quantify disease progression, including the Friedreich Ataxia Rating Scale, examiner-rated functional disability sc...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Friedman, Lisa S, Farmer, Jennifer M, Perlman, Susan, Wilmot, George, Gomez, Christopher, Bushara, Khalaf O, Mathews, Katherine D, Subramony, S. H, Ashizawa, Tetsuo, Balcer, Laura J, Wilson, Robert B, Lynch, David R
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954653/
https://ncbi.nlm.nih.gov/pubmed/20063431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.22912
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky